News Briefing channel feed

UK med­ical re­search group re­veals £100M rare dis­eases pro­gram; Al­lar­i­ty an­nounces $11M of­fer­ing

Last year

Lil­ly to buy Eu­ro­pean ADC biotech; Ab­b­Vie ends SHP2 work with Ja­co­bio

Last year

Hong Kong SPAC nix­es di­ag­nos­tics merg­er; Clay Sie­gall will run a pub­lic biotech again

Last year

Sutro inks $390M roy­al­ty fi­nanc­ing deal with Black­stone; Clin­i­cal hold on Phar­varis' HAE drug lift­ed

Last year

Two biotechs launch pub­lic of­fer­ings; Vaxxin­i­ty shares safe­ty da­ta on its Parkin­son's vac­cine

Last year

Blue­bird gets PDU­FA date for lo­vo-cel; FDA lifts hold on Di­aMed­ica stroke tri­al

Last year

LA­VA Ther­a­peu­tics winds down bis­pe­cif­ic tri­al; Blue Wa­ter buys six mar­ket­ed drugs for $8.5M

Last year

Seagen touts PhII da­ta for Ad­cetris/Op­di­vo com­bo; A-Al­pha part­ners with Gilead on HIV

Last year

FDA sets ac­tion date for Phath­om af­ter trace car­cino­gens led to CRL, grants As­traZeneca pri­or­i­ty re­view

Last year

Mozart Ther­a­peu­tics se­cures $25M ex­pan­sion to Se­ries A; Lian­Bio un­veils PhI­Ia da­ta for gas­tric can­cer treat­ment

Last year

Ital­ian AAV biotech clos­es $65M Se­ries A; GSK's Jem­per­li nabs pri­or­i­ty re­view in en­dome­tri­al can­cer

Last year

Bay­er buys li­cense to Cedil­la pre­clin­i­cal can­cer pro­gram; MEI Phar­ma says no to un­so­licit­ed of­fer

Last year

Seres re­ceives $125M pay­ment from Nestlé; French biotech teas­es ear­ly-stage eye dis­ease da­ta

Last year

Cor­rect­ed: Bench­Sci rais­es $70M Se­ries D for drug dis­cov­ery soft­ware; Zen­tal­is touts PhIb ovar­i­an can­cer da­ta

3 years ago

Boehringer In­gel­heim ex­tends 2020 col­lab with Ox­ford Bio­Ther­a­peu­tics; Eu­ro­pean biotechs claim pos­i­tive PhI I/O da­ta

3 years ago

Ipsen giv­en an ad­comm date for palo­varotene; Am­brx Bio­phar­ma looks to se­cure $75M in lat­est se­cu­ri­ties of­fer­ing

3 years ago

Pri­or­i­ty re­view for Take­da’s ul­tra-rare blood clot ERT; FDA to give an­oth­er look at Arde­lyx’s CKD drug

3 years ago
FDA+

BioX­cel touts healthy vol­un­teer da­ta for neu­ro ther­a­py; Io­n­is, Chi­nook part­ner on rare kid­ney dis­ease

3 years ago

Verve names sec­ond PC­SK9 can­di­date; Ex­sci­en­tia picks an­oth­er AI-cre­at­ed mol­e­cule for clin­ic

3 years ago

Fu­sion and Cyteir re­fo­cus pipelines; Nona Bio­sciences col­lab­o­rat­ing with Phar­maEssen­tia

3 years ago

Deer­field launch­es ra­dio­ther­a­py com­pa­ny; UCLA gene edit­ing spin­out se­cures funds

3 years ago

Leg­end Biotech looks to raise ad­di­tion­al $350M in stock sale; Acasti com­mits to lay­offs

3 years ago

Ak­ili out­lines adult AD­HD da­ta for pre­scrip­tion video game; Medtech start­up to go pub­lic via SPAC

3 years ago

New Jer­sey biotech plans for tiny IPO; Vir gets $10M Gates Foun­da­tion grant for HIV vac­cine

3 years ago
First page Previous page 16171819202122 Next page Last page
A service from the Financial Times